Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenta Nonomura
SGLT2 Inhibitor and GLP-1 Receptor Agonist Combination Therapy Substantially Improved the Renal Function in a Patient With Type 2 Diabetes: Implications for Additive Renoprotective Effects of the Two Drug Classes
Internal Medicine
Internal Medicine
Medicine
Related publications
Combining SGLT2 Inhibitor and GLP-1 Agonist: Exaggerated Weight Loss in a Morbidly Obese Patient With Type 2 Diabetes
British Journal of Diabetes
SGLT2 Inhibitors or GLP-1 Receptor Agonists as Second-Line Therapy in Type 2 Diabetes: Patient Selection and Perspectives
Vascular Health and Risk Management
Qtern: DPP-4 and SGLT2 Inhibitor Combination for Type 2 Diabetes
Prescriber
Pharmacology
Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
DPP-4/SGLT2 Inhibitor Combined Therapy for Type 2 Diabetes
Prescriber
Pharmacology
Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Injections in the Treatment of Type 2 Diabetes
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effective SGLT2 Inhibitor for Patient With Type 2 Diabetes Mellitus (T2DM) and Depression
Dulaglutide: Third Once-Weekly GLP-1 Agonist for Type 2 Diabetes
Pharmacy Today
Ertugliflozin: A New SGLT2 Inhibitor for Type 2 Diabetes
Prescriber
Pharmacology
